The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,063,919 in first-year total cost, median $1,433,673.
Most frequent study sections
- Special Emphasis Panel[ZAI1 MFH-M (M2)]6
Most frequent institutions
- EPIVAX, INC.1
- INTEGRATED BIOTHERAPEUTICS, INC.1
- SCRIPPS RESEARCH INSTITUTE, THE1
- TULANE UNIVERSITY OF LOUISIANA1
- UNIV OF MARYLAND, COLLEGE PARK1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Rationally Designed Pan-Ebolavirus Vaccine1R01AI132204-01 | AMAN, M JAVADSAPHIRE, ERICA OLLMANNSCHIEF, WILLIAM R. | INTEGRATED BIOTHERAPEUTICS, INC., MD | $1,691,927 | ZAI1 |
| 2017 | Structure-based design of novel Lassa virus glycoproteins for vaccine development1R01AI132244-01 | GARRY, ROBERT F | TULANE UNIVERSITY OF LOUISIANA, LA | $1,562,780 | ZAI1 |
| 2017 | Structure-Based Vaccine Design for Hepatits C Virus1R01AI132213-01 | ANDRIANOV, ALEXANDERFOUNG, STEVENFUERST, THOMAS RMARIUZZA, ROY APIERCE, BRIAN G. | UNIV OF MARYLAND, COLLEGE PARK, MD | $1,449,630 | ZAI1 |
| 2017 | Germline targeting influenza immunogens1R01AI132317-01 | NEMAZEE, DAVID | SCRIPPS RESEARCH INSTITUTE, THE, CA | $1,417,715 | ZAI1 |
| 2017 | Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine1R01AI132205-01 | DEGROOT, ANNE SEARLS | EPIVAX, INC., RI | $1,221,150 | ZAI1 |
| 2017 | Structure-Based Design of a Broadly Protective Group A Streptococcal Vaccine1R01AI132117-01 | DALE, JAMES B. | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $720,717 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.